NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.
Also called NCT06511505
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 1,000 participants
- Sponsor
- Registry
-
NCT06511505
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06511505. Randomized; no masking; primary purpose screening. Start 2024-09-16 (actual); primary completion 2027-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
- Acronym
- NOTABLE
- Condition
- Atrial Fibrillation
- Condition
- Cardiovascular Diseases
- Condition
- Arrhythmia
- Condition
- Valvular Disease
- Intervention (Device)
- Risk-Based Assessment for Cardiac Dysfunction
- Lead sponsor
- Northwestern University
- Collaborator
- Tempus AI
Record details
- Record id
cardio:ct-nct06511505- Content hash
e14e7649b5ca3e54283b03ac81f3d8466db55690fb79af9365d69133d8dd8004